S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Stock market today: Wall Street drifts to a mixed finish as yields tick higher
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Stock market today: Wall Street drifts to a mixed finish as yields tick higher
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Stock market today: Wall Street drifts to a mixed finish as yields tick higher
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Stock market today: Wall Street drifts to a mixed finish as yields tick higher
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China

Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Acutus Medical, Inc. stock logo
AFIB
Acutus Medical
$0.17
+6.2%
$0.19
$0.16
$1.09
$5.12M0.191.98 million shs729,302 shs
Accuray Incorporated stock logo
ARAY
Accuray
$2.21
+0.9%
$2.56
$2.17
$4.30
$219.17M1.44439,408 shs693,509 shs
ClearPoint Neuro, Inc. stock logo
CLPT
ClearPoint Neuro
$5.39
-2.5%
$6.69
$4.05
$10.80
$145.91M0.89149,083 shs86,697 shs
Iradimed Corporation stock logo
IRMD
Iradimed
$40.36
-0.3%
$43.28
$36.12
$51.04
$510.96M0.8251,829 shs28,705 shs
Elon Musk's Next Move Cover

Wondering when you'll finally be able to invest in SpaceX, StarLink, or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Acutus Medical, Inc. stock logo
AFIB
Acutus Medical
-1.51%-0.43%-37.75%-2.92%-77.06%
Accuray Incorporated stock logo
ARAY
Accuray
-1.79%-7.59%-14.79%-21.22%-26.26%
ClearPoint Neuro, Inc. stock logo
CLPT
ClearPoint Neuro
-0.90%-10.23%-21.78%-27.71%-47.73%
Iradimed Corporation stock logo
IRMD
Iradimed
-1.36%-1.68%-8.83%-9.02%+0.27%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Acutus Medical, Inc. stock logo
AFIB
Acutus Medical
N/AN/AN/AN/AN/AN/AN/AN/A
Accuray Incorporated stock logo
ARAY
Accuray
3.1818 of 5 stars
3.51.00.04.60.01.70.6
ClearPoint Neuro, Inc. stock logo
CLPT
ClearPoint Neuro
2.1274 of 5 stars
3.54.00.00.02.80.00.6
Iradimed Corporation stock logo
IRMD
Iradimed
4.6827 of 5 stars
3.54.01.74.41.13.31.3

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Acutus Medical, Inc. stock logo
AFIB
Acutus Medical
N/AN/AN/AN/A
Accuray Incorporated stock logo
ARAY
Accuray
3.00
Buy$8.25273.30% Upside
ClearPoint Neuro, Inc. stock logo
CLPT
ClearPoint Neuro
3.00
Buy$12.00122.63% Upside
Iradimed Corporation stock logo
IRMD
Iradimed
3.00
Buy$60.0048.66% Upside

Current Analyst Ratings

Latest IRMD, AFIB, CLPT, and ARAY Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
4/1/2024
Iradimed Corporation stock logo
IRMD
Iradimed
Singular Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy
3/13/2024
ClearPoint Neuro, Inc. stock logo
CLPT
ClearPoint Neuro
Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$8.00 ➝ $9.00
2/13/2024
Accuray Incorporated stock logo
ARAY
Accuray
Roth Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy
2/13/2024
Accuray Incorporated stock logo
ARAY
Accuray
Roth Mkm
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy$9.00
(Data available from 4/18/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Acutus Medical, Inc. stock logo
AFIB
Acutus Medical
$7.16M0.71N/AN/A($0.03) per share-5.74
Accuray Incorporated stock logo
ARAY
Accuray
$447.61M0.49N/AN/A$0.56 per share3.95
ClearPoint Neuro, Inc. stock logo
CLPT
ClearPoint Neuro
$23.95M6.09N/AN/A$0.86 per share6.27
Iradimed Corporation stock logo
IRMD
Iradimed
$65.56M7.79$1.40 per share28.81$5.66 per share7.13

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Acutus Medical, Inc. stock logo
AFIB
Acutus Medical
-$81.66M-$1.24N/AN/A-166.79%-35.31%-13.43%5/9/2024 (Estimated)
Accuray Incorporated stock logo
ARAY
Accuray
-$9.28M-$0.15N/A15.79N/A-3.25%-28.11%-3.05%5/1/2024 (Confirmed)
ClearPoint Neuro, Inc. stock logo
CLPT
ClearPoint Neuro
-$22.09M-$0.91N/AN/AN/A-92.21%-83.94%-47.92%5/9/2024 (Estimated)
Iradimed Corporation stock logo
IRMD
Iradimed
$17.19M$1.3629.68N/A26.22%24.62%20.43%5/2/2024 (Estimated)

Latest IRMD, AFIB, CLPT, and ARAY Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/1/2024N/A
Accuray Incorporated stock logo
ARAY
Accuray
-$0.0050N/A+$0.0050N/AN/AN/A  
3/12/2024Q4 2023
ClearPoint Neuro, Inc. stock logo
CLPT
ClearPoint Neuro
-$0.22-$0.19+$0.03-$0.19$6.40 million$6.81 million
2/8/2024Q4 2023
Iradimed Corporation stock logo
IRMD
Iradimed
$0.37$0.36-$0.01$0.36N/A$17.45 million
1/31/202412/31/2023
Accuray Incorporated stock logo
ARAY
Accuray
-$0.05-$0.10-$0.05-$0.10$107.11 million$107.24 million    

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Acutus Medical, Inc. stock logo
AFIB
Acutus Medical
N/AN/AN/AN/AN/A
Accuray Incorporated stock logo
ARAY
Accuray
N/AN/AN/AN/AN/A
ClearPoint Neuro, Inc. stock logo
CLPT
ClearPoint Neuro
N/AN/AN/AN/AN/A
Iradimed Corporation stock logo
IRMD
Iradimed
$0.601.49%N/A44.12%N/A

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Acutus Medical, Inc. stock logo
AFIB
Acutus Medical
1.10
2.44
2.22
Accuray Incorporated stock logo
ARAY
Accuray
3.53
1.58
0.84
ClearPoint Neuro, Inc. stock logo
CLPT
ClearPoint Neuro
0.47
4.87
3.80
Iradimed Corporation stock logo
IRMD
Iradimed
N/A
4.65
3.87

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Acutus Medical, Inc. stock logo
AFIB
Acutus Medical
56.91%
Accuray Incorporated stock logo
ARAY
Accuray
64.08%
ClearPoint Neuro, Inc. stock logo
CLPT
ClearPoint Neuro
30.08%
Iradimed Corporation stock logo
IRMD
Iradimed
92.34%

Insider Ownership

CompanyInsider Ownership
Acutus Medical, Inc. stock logo
AFIB
Acutus Medical
3.50%
Accuray Incorporated stock logo
ARAY
Accuray
3.78%
ClearPoint Neuro, Inc. stock logo
CLPT
ClearPoint Neuro
6.11%
Iradimed Corporation stock logo
IRMD
Iradimed
42.60%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Acutus Medical, Inc. stock logo
AFIB
Acutus Medical
23029.72 million28.68 millionOptionable
Accuray Incorporated stock logo
ARAY
Accuray
1,02499.17 million95.42 millionOptionable
ClearPoint Neuro, Inc. stock logo
CLPT
ClearPoint Neuro
10727.07 million25.42 millionOptionable
Iradimed Corporation stock logo
IRMD
Iradimed
14812.66 million7.27 millionOptionable

IRMD, AFIB, CLPT, and ARAY Headlines

SourceHeadline
Iradimeds (IRMD) "Buy" Rating Reaffirmed at Singular ResearchIradimed's (IRMD) "Buy" Rating Reaffirmed at Singular Research
marketbeat.com - April 5 at 8:20 AM
Iradimed Corporation (NASDAQ:IRMD) Sees Significant Increase in Short InterestIradimed Corporation (NASDAQ:IRMD) Sees Significant Increase in Short Interest
marketbeat.com - April 2 at 7:37 AM
Resource Consulting Group Inc. Purchases New Stake in IRadimed Co. (NASDAQ:IRMD)Resource Consulting Group Inc. Purchases New Stake in IRadimed Co. (NASDAQ:IRMD)
marketbeat.com - March 20 at 12:49 PM
IRadimed Co. (NASDAQ:IRMD) Sees Significant Growth in Short InterestIRadimed Co. (NASDAQ:IRMD) Sees Significant Growth in Short Interest
marketbeat.com - March 18 at 2:46 PM
IRMD Jul 2024 60.000 callIRMD Jul 2024 60.000 call
finance.yahoo.com - March 15 at 11:41 PM
IRADIMED CORPORATION To Participate at the 36th Annual Roth ConferenceIRADIMED CORPORATION To Participate at the 36th Annual Roth Conference
globenewswire.com - March 13 at 4:30 PM
iRadimed Corp.iRadimed Corp.
wsj.com - March 13 at 7:43 AM
Winter Springs’ IRadimed Advancing MRI Patient Care With Portable PumpsWinter Springs’ IRadimed Advancing MRI Patient Care With Portable Pumps
orlandomagazine.com - March 1 at 12:42 PM
Calculating The Intrinsic Value Of IRadimed Corporation (NASDAQ:IRMD)Calculating The Intrinsic Value Of IRadimed Corporation (NASDAQ:IRMD)
finance.yahoo.com - February 26 at 6:49 AM
Calculating The Intrinsic Value Of IRadimed Corporation (NASDAQ:IRMD)Calculating The Intrinsic Value Of IRadimed Corporation (NASDAQ:IRMD)
finance.yahoo.com - February 26 at 6:49 AM
Should You Invest in IRadimed Corporation (IRMD)?Should You Invest in IRadimed Corporation (IRMD)?
finance.yahoo.com - February 19 at 1:54 PM
IRMD Mar 2024 40.000 callIRMD Mar 2024 40.000 call
finance.yahoo.com - February 17 at 10:40 AM
IRMD Mar 2024 45.000 putIRMD Mar 2024 45.000 put
finance.yahoo.com - February 17 at 10:40 AM
IRMD Feb 2024 44.520 callIRMD Feb 2024 44.520 call
finance.yahoo.com - February 15 at 10:29 AM
Institutional investors own a significant stake of 39% in IRadimed Corporation (NASDAQ:IRMD)Institutional investors own a significant stake of 39% in IRadimed Corporation (NASDAQ:IRMD)
finance.yahoo.com - February 11 at 10:04 AM
IRadimed Corporation (NASDAQ:IRMD) Q4 2023 Earnings Call TranscriptIRadimed Corporation (NASDAQ:IRMD) Q4 2023 Earnings Call Transcript
finance.yahoo.com - February 9 at 10:52 AM
iRadimed Corp (IRMD) Reports Record Revenues and Robust Earnings Growth in Q4 and Full-Year 2023iRadimed Corp (IRMD) Reports Record Revenues and Robust Earnings Growth in Q4 and Full-Year 2023
finance.yahoo.com - February 8 at 1:36 PM
IRADIMED CORPORATION Announces Fourth Quarter of 2023 and Full Year of 2023 Financial ResultsIRADIMED CORPORATION Announces Fourth Quarter of 2023 and Full Year of 2023 Financial Results
markets.businessinsider.com - February 8 at 8:36 AM
IRadimed: Q4 Earnings SnapshotIRadimed: Q4 Earnings Snapshot
washingtonpost.com - February 8 at 8:36 AM
iRadimeds Earnings OutlookiRadimed's Earnings Outlook
benzinga.com - February 7 at 5:33 PM
iRadimed Q4 2023 Earnings PreviewiRadimed Q4 2023 Earnings Preview
msn.com - February 7 at 12:32 PM
Lake Street Reaffirms Their Buy Rating on Iradimed (IRMD)Lake Street Reaffirms Their Buy Rating on Iradimed (IRMD)
markets.businessinsider.com - February 7 at 12:54 AM
IRADIMED CORPORATION to Hold 2023 Fourth Quarter Financial Results Conference Call on February 8th.IRADIMED CORPORATION to Hold 2023 Fourth Quarter Financial Results Conference Call on February 8th.
finance.yahoo.com - February 1 at 8:24 PM
IRadimed: Caution On The Valuation Of This Excellent CompanyIRadimed: Caution On The Valuation Of This Excellent Company
seekingalpha.com - February 1 at 12:44 AM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Company Descriptions

Acutus Medical logo

Acutus Medical

NASDAQ:AFIB
Acutus Medical, Inc., an arrhythmia management company, designs, manufactures, and markets various tools for catheter-based ablation procedures to treat various arrhythmias in the United States and internationally. Its product portfolio includes novel access sheaths, transseptal crossing tools, diagnostic and mapping catheters, conventional and contact force ablation catheters, and mapping and imaging consoles and accessories, as well as supporting algorithms and software programs. The company was incorporated in 2011 and is headquartered in Carlsbad, California.
Accuray logo

Accuray

NASDAQ:ARAY
Accuray Incorporated designs, develops, manufactures, and sells radiosurgery and radiation therapy systems for the treatment of tumors in the United States, Canada, Latin America, Australia, New Zealand, Europe, the Middle East, India, Africa, Japan, China, and rest of the Asia Pacific region. It offers the CyberKnife System, a robotic stereotactic radiosurgery and stereotactic body radiation therapy system used for the treatment of primary and metastatic tumors outside the brain, including tumors on or near the spine and in the breast, kidney, liver, lung, pancreas, and prostate. The company also provides the TomoTherapy System, including the Radixact System, which allows for integrated radiation treatment planning, delivery, and data management, enabling clinicians to deliver ultra-precise treatments to approximately 50 patients per day; iDMS data management system, a fully integrated treatment planning and data management systems; and Accuray precision treatment planning system, a treatment planning and data management systems. In addition, it offers post-contract customer support, installation, training, and other professional services. The company primarily markets its products directly to customers, including hospitals and stand-alone treatment facilities through its sales organization, as well as to customers through sales agents and group purchasing organizations in the United States; and to customers directly and through distributors and sales agents internationally. Accuray Incorporated was incorporated in 1990 and is headquartered in Madison, Wisconsin.
ClearPoint Neuro logo

ClearPoint Neuro

NASDAQ:CLPT
ClearPoint Neuro, Inc. operates as a medical device company primarily in the United States. It develops and commercializes platforms for performing minimally invasive surgical procedures in the brain under magnetic resonance imaging guided interventions. The company offers ClearPoint system, an integrated system for the insertion of deep brain stimulation electrodes, biopsy needles, and laser catheters, as well as the infusion of pharmaceuticals into the brain. It has license and collaboration agreement with Clinical Laserthermia Systems AB; license and research agreement with Koninklijke Philips N.V., UCB Biopharma SRL, and University of California and San Francisco; and development and license agreement with NE Scientific, LLC. The company was formerly known as MRI Interventions, Inc. and changed its name to ClearPoint Neuro, Inc. in February 2020. ClearPoint Neuro, Inc. was incorporated in 1998 and is headquartered in Solana Beach, California.
Iradimed logo

Iradimed

NASDAQ:IRMD
IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible medical devices and related accessories, and disposables and services in the United States and internationally. It offers MRidium MRI compatible intravenous (IV) infusion pump system with associated disposable IV tubing sets; MRI compatible patient vital signs monitoring system; and 3600 FMD1 with RALU ferromagnetic detection device. The company also provides non-magnetic IV poles, wireless remote displays/controls, side car pump modules, dose error reduction systems, and SpO2 monitoring with sensors and accessories. It serves hospitals, acute care facilities, and outpatient imaging centers. The company sells its products through direct field sales representatives, regional sales directors, clinical application specialists, and independent distributors. IRADIMED CORPORATION was incorporated in 1992 and is headquartered in Winter Springs, Florida.